News
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the ...
Baxter and chemical and materials engineering professors Kara McCloskey and Roberto Andresen Eguiluz, both affiliated with ...
Some of the best CBD cream products in high demand often combine cannabidiol with herbs and organic compounds, such as arnica ...
Hawaiʻi's Department of Health offers free medical cannabis education courses for healthcare providers, covering the ...
Hundreds of peer-reviewed studies on marijuana and its components have been published in the first seven months of 2025, ...
A Wisconsin company that was to utilise hemp in the manufacture of new generation batteries appears to have gone belly-up.
CardiolRx did not have a significant impact on left ventricular extracellular volume (LV-ECV) in the Phase II ARCHER study.
3don MSNOpinion
I'm open to reforms against 'juicing up' hemp products with synthetic cannabinoids, but target regulations shouldn't be so ...
New research shows that CBD may suppress metastasis in pancreatic cancer by disrupting molecular drivers of tumor cell ...
Removal of language from a bill that would have heavily impacted the USA's hemp industry has been welcomed by the U.S. Hemp Roundtable.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results